Amunix secures $117M to move lead candidate to clinical trials
March 4, 2021 -- Amunix Pharmaceuticals has raised $117 million in financing to fund the advancement of its lead T-cell engager candidate into the clinic. Read More
Amgen to acquire Five Prime Therapeutics for $1.9B
March 4, 2021 -- Amgen has agreed to acquire Five Prime Therapeutics for approximately $1.9 billion, adding Five Prime's pipeline of therapeutic antibodies to its oncology portfolio. Read More
Beckman Coulter launches new benchtop cell sorter
March 4, 2021 -- Beckman Coulter Life Sciences has launched its Cytoflex SRT benchtop cell sorter that features expanded laser and color options. Read More
Merck gets $269M to ramp up COVID-19 vaccine manufacturing
March 3, 2021 -- Merck has received about $269 million in U.S. funding to expand manufacturing capacity and supply of SARS-CoV-2/COVID-19 vaccines and medicines. Read More
Century Therapeutics closes $160M to advance preclinical cell therapies
March 3, 2021 -- Century Therapeutics has closed $160 million in financing to advance its preclinical pipeline of induced pluripotent stem cell-derived chimeric antigen receptor-iT and CAR-i natural killer cell products. Read More
Caribou nabs $115M to advance CRISPR-edited cell therapies
March 3, 2021 -- Caribou Biosciences has completed $115 million in financing to further develop its next-generation CRISPR technology platform and advance its pipeline of allogeneic immune cell therapies for oncology. Read More
Promega launches new ADCC bioassay
March 3, 2021 -- Promega has partnered with BioIVT to develop a new bioassay to measure the antibody-dependent cellular cytotoxicity (ADCC) of antibodies during drug development and characterization. Read More
DNA Script to contribute to DARPA's mobile vaccine manufacturing platform
March 2, 2021 -- DNA Script has been selected by GE Research to join a collaboration to develop a rapid response, mobile medical manufacturing platform to enable on-demand production of nucleic acid-based vaccines and therapies. The project is part of a Defense Advanced Research Projects Agency (DARPA) program. Read More
Phio, AgonOx partner on T cell-based cancer immunotherapies
March 1, 2021 -- Phio Pharmaceuticals and AgonOx have announced a partnership to develop T cell-based cancer immunotherapies. Read More
Rebus Biosystems debuts its Epser spatial omics platform
March 1, 2021 -- Rebus Biosystems has debuted its Esper spatial omics platform to advance the study of tissue biology and innovations in neuroscience, cancer, infectious disease, and immunology research. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter